Q&M’s PATMI for the 2QFY2021 beat his expectations slightly due to the continued expansion of its dental clinics and its ramping up of testing operations.
Analysts at CGS-CIMB Research, Maybank Kim Eng and PhillipCapital are remaining positive on Q&M with ‘add’ and ‘buy’ calls.
Maybank Kim Eng analyst Eric Ong has lifted Q&M’s target price estimate to $1.03 from 87 cents previously.
